Refolo LM - Search Results

1

Common Alzheimer's Disease Research Ontology: National Institute on Aging and Alzheimer's Association collaborative project.

Refolo LM, Snyder H, Liggins C, Ryan L, Silverberg N, Petanceska S, Carrillo MC. Refolo LM, et al. Alzheimers Dement. 2012 Jul;8(4):372-5. doi: 10.1016/j.jalz.2012.05.2115. Alzheimers Dement. 2012. PMID: 22748941

2

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Refolo LM, Pappolla MA, LaFrancois J, Malester B, Schmidt SD, Thomas-Bryant T, Tint GS, Wang R, Mercken M, Petanceska SS, Duff KE. Refolo LM, et al. Neurobiol Dis. 2001 Oct;8(5):890-9. doi: 10.1006/nbdi.2001.0422. Neurobiol Dis. 2001. PMID: 11592856

3

Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis.

Pappolla MA, Smith MA, Bryant-Thomas T, Bazan N, Petanceska S, Perry G, Thal LJ, Sano M, Refolo LM. Pappolla MA, et al. Among authors: refolo lm. Free Radic Biol Med. 2002 Jul 15;33(2):173-81. doi: 10.1016/s0891-5849(02)00841-9. Free Radic Biol Med. 2002. PMID: 12106813 Review.

4

Statin therapy for Alzheimer's disease: will it work?

Petanceska SS, DeRosa S, Olm V, Diaz N, Sharma A, Thomas-Bryant T, Duff K, Pappolla M, Refolo LM. Petanceska SS, et al. Among authors: refolo lm. J Mol Neurosci. 2002 Aug-Oct;19(1-2):155-61. doi: 10.1007/s12031-002-0026-2. J Mol Neurosci. 2002. PMID: 12212773

5

Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding.

Parvathy S, Ehrlich M, Pedrini S, Diaz N, Refolo L, Buxbaum JD, Bogush A, Petanceska S, Gandy S. Parvathy S, et al. J Neurochem. 2004 Aug;90(4):1005-10. doi: 10.1111/j.1471-4159.2004.02521.x. J Neurochem. 2004. PMID: 15287907 Free article.

6

Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels.

Pacheco-Quinto J, Rodriguez de Turco EB, DeRosa S, Howard A, Cruz-Sanchez F, Sambamurti K, Refolo L, Petanceska S, Pappolla MA. Pacheco-Quinto J, et al. Neurobiol Dis. 2006 Jun;22(3):651-6. doi: 10.1016/j.nbd.2006.01.005. Epub 2006 Mar 3. Neurobiol Dis. 2006. PMID: 16516482

7

NIA commentary: translational issues in Alzheimer's disease drug development.

Buckholtz NS, Ryan LM, Petanceska S, Refolo LM. Buckholtz NS, et al. Among authors: refolo lm. Neuropsychopharmacology. 2012 Jan;37(1):284-6. doi: 10.1038/npp.2011.116. Neuropsychopharmacology. 2012. PMID: 22157857 Free PMC article. No abstract available.

8

International Alzheimer's Disease Research Portfolio (IADRP) aims to capture global Alzheimer's disease research funding.

Liggins C, Snyder HM, Silverberg N, Petanceska S, Refolo LM, Ryan L, Carrillo MC. Liggins C, et al. Among authors: refolo lm. Alzheimers Dement. 2014 May;10(3):405-8. doi: 10.1016/j.jalz.2013.12.013. Alzheimers Dement. 2014. PMID: 24780512

9

Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchers.

Snyder HM, Shineman DW, Friedman LG, Hendrix JA, Khachaturian A, Le Guillou I, Pickett J, Refolo L, Sancho RM, Ridley SH. Snyder HM, et al. Alzheimers Dement. 2016 Nov;12(11):1177-1185. doi: 10.1016/j.jalz.2016.07.001. Alzheimers Dement. 2016. PMID: 27836053

10

Modulation of A(beta) peptides by estrogen in mouse models.

Zheng H, Xu H, Uljon SN, Gross R, Hardy K, Gaynor J, Lafrancois J, Simpkins J, Refolo LM, Petanceska S, Wang R, Duff K. Zheng H, et al. Among authors: refolo lm. J Neurochem. 2002 Jan;80(1):191-6. doi: 10.1046/j.0022-3042.2001.00690.x. J Neurochem. 2002. PMID: 11796757 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters